Special Symposium
Calendar Export
Why are we having this Symposium? Recent regulatory actions by FDA/EMEA regarding late-stage approval for PARPi in recurrent ovarian cancer
Session Name
How to interpret overall survival data with PARP inhibitors
(ID 3)
Speakers
Robert L. Coleman
(The Woodlands, TX, United States of America)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes